Developing Innovative Solutions To Treat Drug-Resistant Infections
TaBriX focuses on the development of drugs that target novel, unexplored biological pathways to fight difficult-to-treat infections, such as tuberculosis, and tackle the global threat of drug resistance.
Global Threat
About TaBriX
Industry Links
latest news
TaBriX welcomes first private investment
TaBriX has welcomed their first private investment to fund their work.
TaBriX receives award from the ERDF
TaBriX has received an award from the European Regional Development Fund Research and Innovation Hea…
TaBriX awarded by UoM Innovation Factory
TaBriX has recently received a Proof-of-Principle award from the University of Manchester Innovation…
Get in Touch
We are looking for support and investment to help us achieve our important goals. To Find out how you can support TaBriX, contact us at us at the link below.
